Latest Breaking News On - Cubist pharmaceuticals - Page 6 : comparemela.com

Pfizer s migraine market chief joins Apnimed—Chutes & Ladders

Pfizer s migraine market chief joins Apnimed—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesPaul willemsMadam townsendSamuel collinsMary lynne hedleyKirk shepardBristol myers squibbCarrie brownsteinNelson ambrogioKaya pai panandikerJohna nortonImmorta bioDavid ricksKyle rasbachDiem nguyen

DiaMedica Therapeutics Inc (DMAC) Appoints Lorianne Masuoka as Chief Medical Officer

DiaMedica Therapeutics Inc (DMAC) Appoints Lorianne Masuoka as Chief Medical Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRick paulsMarinus pharmaceuticalsPfenex incDiamedica therapeutics incNektar therapeuticsUniversity of californiaYale universityCubist pharmaceuticalsOpiant pharmaceuticalsDiamedica therapeuticsLorianne masuokaChief medicalChief executiveChief medical officerEpygenix therapeutics

Global Pseudomonas Aeruginosa Infection Treatment Market

Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) The

South africaSouth koreaUnited statesUnited kingdomTyumenskaya oblastAsia pacificSeika pharmaCompany profilesCubist pharmaceuticalsMerck co incTetraphase pharmaceuticalsBayer agPfizer incGilead sciences incRoute of administrationExhaustive company profiles of the top

DiaMedica Therapeutics Appoints Dr Lorianne Masuoka as Chief Medical Officer

Executive with Strong Track Record in Advancing Pipelines Through Clinical Development .

United statesSouth koreaKyonggi doRick paulsUniversity of californiaDiamedica therapeutics incYale universityOpiant pharmaceuticalsPfenex incMarinus pharmaceuticals nasdaqCubist pharmaceuticalsExchange commissionDiamedica therapeuticsLorianne masuokaChief medicalChief executive

Global Pseudomonas Aeruginosa Infection Treatment Market Report 2024-2034: Rising Antibiotic Resistance Drives Demand for Pseudomonas Aeruginosa Infection Treatments

/PRNewswire/ The "Global Pseudomonas Aeruginosa Infection Treatment Market" report has been added to ResearchAndMarkets.com s offering. The global.

South koreaUnited kingdomUnited statesSouth africaTyumenskaya oblastLaura woodAsia pacificSeika pharmaAbbott laboratoriesE st office hours callOffice hours callPfizer incRoche holdingCubist pharmaceuticalsMerck co incExhaustive company profiles of the top